Trending News
News
News
Gene Therapy Protocol at UCSD Activates Immune System in Patients with Leukemia
Researchers report that the patients with CLL who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells.
News
Thermo Scientific LTQ Orbitrap™ Mass Spectrometer Selected for Research in Disease Treatment and Prevention
The Thermo Scientific LTQ Orbitrap was chosen to play a major role in IRCM’s systematic analysis of human protein interaction networks.
News
Quotient BioResearch Acquires BioDynamics
BioDynamics, a specialist provider of metabolism, bioanalytical and radiochemistry services, represents the fourth acquisition to date for Quotient BioResearch.
News
Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
Biomoda and Medical Acoustics will collect lung sputum samples in an upcoming clinical study that will use Biomoda's proprietary testing technology for detection of early lung cancer.
News
Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
Marshfield Clinic has announced an article published in Blood Online entitled “CYP4F2 genetic variant alters required warfarin dose.”
News
Eisai and Accenture Launch Clinical Data Management in India under Global Outsourcing Agreement
Accenture will provide Eisai with clinical data management services through its delivery center in Chennai, Tamil Nadu, India.
News
KRIBB and Chemizon Announce Collaboration
Chemizon collaborates with KRIBB to spin out a new biotech company designed to commercialize KRIBB’s diverse portfolio of intellectual property assets.
News
Compugen Announces In-Vivo Results for Two Novel Peptide Agonists of MAS GPCR
The two peptides – CGEN-856 and CGEN-857 – were identified using the Company’s previously announced GPCR ligand discovery platform.
News
IBM and University Researchers to Develop Research Tools to Improve Cancer Patient Outcomes
Advanced imaging and computer technologies aimed at providing for reliable prognosis leading to more personalized treatment.
News
Isis Announces $2.8 Million in Government Grants and Contracts Awarded to its Ibis Subsidiary
Ibis has been awarded two new Phase 2 SBIR grants and a new government contract to advance its pathogen identification technology.
Advertisement